Antivirals
Found 766 products of "Antivirals"
Zanamivir Azide Methyl Ester
CAS:Controlled ProductApplications An intermediate used in the preparation of Zanamivir derivatives.
References Andrews, D., et al.: Eur. J. Med. Chem., 34, 563 (1999), Altamore, T., et al.: Bioorg. Med. Chem., 14, 1126 (2006),Formula:C12H18N4O7Color and Shape:NeatMolecular weight:330.29(S)-Methyl 3-(4,4-difluorocyclohexanecarboxamido)-3-phenylpropanoate
CAS:Controlled ProductFormula:C17H21F2NO3Color and Shape:NeatMolecular weight:325.355S-2-Amino-5-dibenzylamino-4-oxo-1,6-diphenylhex-2-ene
CAS:Controlled ProductApplications An intermediate in the synthesis of Ritonavir.
References Sham, H., et al.: Bioorg. Med. Chem. Lett., 12, 3101 (2002),Formula:C32H32N2OColor and Shape:NeatMolecular weight:460.61Ivermectin 8α-hydroperoxide
**Ivermectin 8α-hydroperoxide** is a derivative of the antiparasitic agent ivermectin, which is synthesized through chemical modification. Ivermectin originally derives from the fermentation products of the bacterium *Streptomyces avermitilis*. The modification to form 8α-hydroperoxide involves the addition of a hydroperoxide group, potentially altering its biological properties.Formula:C48H74O16Purity:Min. 95%Molecular weight:907.09 g/molBalapiravir
CAS:Balapiravir is an antiviral agent, which is a synthetic derivative based on natural compounds, specifically designed to inhibit the replication of various viral pathogens. The source of Balapiravir integrates bio-based elements with modifications to enhance its therapeutic efficacy.Formula:C21H30N6O8Purity:Min. 95%Molecular weight:494.5 g/molSofosbuvir - Bio-X ™
CAS:Sofosbuvir is an antiviral agent that is used for the treatment of hepatitis C infections and is used in combination with other antiviral agents. This drug is an inhibitor of viral RNA polymerase called non-structural protein 5B (NS5B). As a result, it inhibits viral RNA replication.
Formula:C22H29FN3O9PPurity:Min. 95%Color and Shape:PowderMolecular weight:529.45 g/molFaldaprevir
CAS:Hepatitis C virus protease inhibitorFormula:C40H49BrN6O9SPurity:Min. 95%Color and Shape:White PowderMolecular weight:869.82 g/molLobucavir
CAS:Lobucavir is an antiviral compound with a mode of action that inhibits viral DNA polymerase. It is used for treating infections caused by herpesviruses and hepatitis B virus.
Formula:C11H15N5O3Purity:Min. 95%Molecular weight:265.27 g/mol8-epiAtazanavir
CAS:8-epiAtazanavir is a stereoisomer of the antiretroviral drug Atazanavir, which is derived from synthetic sources. It acts as an HIV-1 protease inhibitor, where it binds to the active site of the viral protease enzyme, thereby preventing the cleavage of precursor proteins required for the maturation of infectious viral particles. This interference with viral replication is achieved by the structural mimicry of the natural substrate of the protease, allowing it to competitively inhibit the enzyme's activity.Formula:C38H52N6O7Purity:Min. 95%Molecular weight:704.38975Foscarnet sodium
CAS:Foscarnet sodium is a pyrophosphate analog antiviral agent with action on viral DNA polymerase and is used for treating cytomegalovirus and herpes simplex virus infections.
Formula:CNa3O5PPurity:Min. 95%Color and Shape:White PowderMolecular weight:191.95 g/molIndinavir monohydrate
CAS:Indinavir monohydrate is an antiretroviral medication, which is a synthetic pharmaceutical compound, specifically a protease inhibitor, used in the treatment of HIV infection. It is derived from chemical synthesis processes that follow rigorous standards to produce a pharmacologically active compound. Indinavir functions by selectively inhibiting the HIV-1 protease enzyme, which is crucial for the viral replication cycle. By binding to the active site of the enzyme, indinavir prevents the cleavage of viral polypeptides, leading to the production of immature and non-infectious viral particles.Purity:Min. 95%Darunavir-D9
CAS:Darunavir-D9 is a prodrug of darunavir, which is an HIV protease inhibitor. Darunavir-D9 has been shown to be bioequivalent in pharmacokinetic parameters to darunavir given as a tablet. The drug exhibits a low plasma concentration profile and high clearance values. This may be due to rapid absorption and distribution of the drug, with a short elimination half-life. Darunavir-D9 also has little effect on the matrix effect and reproducibility of the reaction monitoring assay, making it an ideal candidate for use in clinical trials.Formula:C27H28D9N3O7SPurity:Min. 95%Molecular weight:556.72 g/molVicriviroc
CAS:Vicriviroc is an investigational pharmaceutical compound, specifically classified as an HIV entry inhibitor. It originates from a synthetic source, designed to target the CCR5 co-receptor on human immune cells. The mode of action involves blocking this co-receptor, thereby preventing the HIV virus from binding and fusing with the host cell membrane. This inhibition effectively obstructs the virus's ability to enter and infect the host cells, particularly those within the chemokine receptor family.
Formula:C28H38F3N5O2Purity:Min. 95%Molecular weight:533.63 g/molViramidine hydrochloride
CAS:Viramidine hydrochloride is an antiviral prodrug with action as a precursor to ribavirin, targeting viral RNA synthesis and is used for research on hepatitis C and other viral infections.Formula:C8H14ClN5O4Purity:Min. 95%Molecular weight:279.68 g/molVicriviroc malate
CAS:Vicriviroc malate is a CCR5 antagonist with action on blocking HIV entry into cells by targeting the CCR5 receptor and is used for research on HIV treatment.Formula:C28H38F3N5O2•C4H6O5Purity:Area-% Min. 90 Area-%Color and Shape:PowderMolecular weight:667.72 g/molPeramivir
CAS:Selective and potent inhibitor of sialidases (neuraminidases) in influenza A and B viruses. The compound binds tightly to the viral neuraminidase active site in late stages of viral life-cycle. It inhibits shedding sialic acids from host cell surface glycans, which interact with viral hemagglutinin, and consequently prevents release of new viral particles from the host cell surface.
Formula:C15H28N4O4Purity:Min. 95%Color and Shape:PowderMolecular weight:328.41 g/molGalidesivir dihydrochloride
CAS:Galidesivir dihydrochloride is an investigational antiviral drug, which is a synthetic nucleoside analogue with broad-spectrum activity. It is derived from a modified adenosine analog structure, targeting viral RNA-dependent RNA polymerases. Galidesivir functions through the incorporation into viral RNA, leading to premature termination of RNA synthesis, effectively inhibiting viral replication. This mechanism aligns with its utility in combating various RNA viruses.Formula:C11H15N5O3•(HCl)2Purity:Min. 95%Molecular weight:338.19 g/molBCX 4430 hydrochloride
CAS:RNA polymerase (RdRp) inhibitor
Formula:C11H15N5O3Purity:Min. 95%Molecular weight:265.27 g/molZiresovir
CAS:Respiratory syncytial virus (RSV) fusion (F) protein inhibitorFormula:C22H25N5O3SPurity:Min. 95%Color and Shape:PowderMolecular weight:439.53 g/molBET-BAY 002
CAS:BET-BAY 002 is an effective BET bromodomain inhibitor demonstrating efficacy in vivo and in vitro against multiple myeloma and leukaemia models.Formula:C22H18ClN5OColor and Shape:SolidMolecular weight:403.86
